Passkey

About:

Passkey Therapeutics is pioneering a new class of medicines, Synergistic Multifunctional Therapeutics (SMThs).

Top Investors: Alexandria Venture Investments, Innovation Endeavors, Breakout Ventures, Wireframe Ventures, Bison Ventures

Description:

Passkey Therapeutics is pioneering a new class of medicines, Synergistic Multifunctional Therapeutics (SMThs). It is designed to address complex diseases by targeting rare combinations of proteins that work together.

Total Funding Amount:

$20M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2022-01-01

Founders:

Bruce Beutel, Soumya Ray, William Chen

Number of Employees:

11-50

Last Funding Date:

2024-10-22

IPO Status:

Private

Industries: